CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Leerink Partners Upgrades Replimune Group to Outperform From Market Perform, Adjusts Price Target to $17 From $11

Positive
AI Analysis

Summary

Leerink Partners upgraded Replimune Group to Outperform from Market Perform and raised its price target to $17 from $11.

Importance:3/10
Sentiment:
0.70
analyst_upgradeprice_target_increaseequity_research
Related Companies

Read the original article

Published by yahoo_finance on August 4, 2026 11:44 AM

Read Original